Novo Nordisk
NVO
NVO
425 hedge funds and large institutions have $6.26B invested in Novo Nordisk in 2013 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 165 increasing their positions, 140 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more call options, than puts
Call options by funds: $66.4M | Put options by funds: $61M
1.29% less ownership
Funds ownership: 84.64% → 83.35% (-1.3%)
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
Holders
425
Holding in Top 10
11
Calls
$66.4M
Puts
$61M
Top Buyers
| 1 | +$70.1M | |
| 2 | +$57.8M | |
| 3 | +$36.4M | |
| 4 |
CCM
Chautauqua Capital Management
Boulder,
Colorado
|
+$25.3M |
| 5 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
+$23.5M |
Top Sellers
| 1 | -$179M | |
| 2 | -$41.1M | |
| 3 | -$33.1M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$17.5M |
| 5 |
Bank of New York Mellon
New York
|
-$16.9M |